Upgrade to SI Premium - Free Trial

Benchmark Starts DexCom (DXCM) at Buy

May 11, 2026 4:20 PM
Benchmark analyst Bruce Jackson initiates coverage on DexCom (NASDAQ: DXCM) with a Buy rating.The analyst comments "We are initiating coverage ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments New Coverage